Directory

>

Sharon Muentener

Sharon Muentener

Vice President, FP&A | Generate:Biomedicines

Winchester, Massachusetts, United States

View contact details (it's free)

Sharon Muentener

Summary

Sharon Muentener is a seasoned financial executive with extensive experience in financial planning and analysis within the biotechnology and pharmaceutical sectors. Currently serving as the VP of FP&A at Generate Biomedicines, she has held leadership roles at notable companies including Crispr Therapeutics and Moderna. With a strong foundation in corporate finance, mergers, and valuation, Sharon has a proven track record of driving financial strategies that support corporate growth. She holds an MBA from Harvard Business School and a B.S. in Accounting and Finance from Georgetown University. Sharon's career reflects a blend of operational expertise and strategic insight, making her an asset in any high-stakes financial environment. Beyond her professional achievements, Sharon is passionate about leveraging financial analytics to foster innovation in the biotech industry.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Consulting Experience

Sharon Muentener

Work Experience

company logo

Vice President, FP&A at

Generate:Biomedicines

March 2022 - Present

company logo

Executive Director, FP&A at

CRISPR Therapeutics

November 2019 - February 2022

💼

Senior Director Financial Planning Analysis at

Moderna, Inc.

October 2018 - November 2019

company logo

Director, Financial Planning and Analysis- Ventures at

Moderna Therapeutics

August 2016 - October 2018

company logo

Associate Director, Strategic Corporate Finance at

Biogen

July 2013 - August 2016

company logo

Specialist at

McKinsey & Company Inc

January 2009 - January 2013

company logo

Expert at

McKinsey & Company Inc

January 2013 - January 2013

company logo

Equity Research Associate at

Fidelity Investments

January 2004 - January 2007

Logos provided by Logo.dev

Sharon Muentener

Education

Harvard Business School, Master Of Business Administration (Mba)

January 2007 - January 2009

Georgetown University, Bachelor Of Science (B.S.)

January 2000 - January 2004

Frequently Asked Questions about Sharon Muentener

What is Sharon Muentener email address?

Sharon Muentener's primary email address is **********@generatebiomedicines.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Sharon Muentener work for?

Sharon Muentener is a Vice President, FP&A at Generate:Biomedicines, a company specializing in Commercial physical research.

Where Sharon Muentener graduated from?

Sharon Muentener holds a degree in from Harvard Business School.

How can I directly contact Sharon Muentener?

To contact Sharon Muentener directly, you can use the email address **********@generatebiomedicines.com. Complete contact information is available upon registration with Muraena.

Who is Sharon Muentener?

Sharon Muentener is a seasoned financial executive with extensive experience in financial planning and analysis within the biotechnology and pharmaceutical sectors. Currently serving as the VP of FP&A at Generate Biomedicines, she has held leadership roles at notable companies including Crispr Therapeutics and Moderna. With a strong foundation in corporate finance, mergers, and valuation, Sharon has a proven track record of driving financial strategies that support corporate growth. She holds an MBA from Harvard Business School and a B.S. in Accounting and Finance from Georgetown University. Sharon's career reflects a blend of operational expertise and strategic insight, making her an asset in any high-stakes financial environment. Beyond her professional achievements, Sharon is passionate about leveraging financial analytics to foster innovation in the biotech industry.

Sharon`s contact details

mail

**********@generatebiomedicines.com

Colleagues

avatar
Sahm Nasseri

Senior Vice President, Business Development and Strategy

avatar
Gevorg Grigoryan

Founding CTO

avatar
Stephen Kottmann

VP Informatics, Engineering

avatar
Nicole Clouse

Vice President, Head of Intellectual Property

avatar
Kaggen Ausma

Head of Corporate Strategy, Chief of Staff

avatar
Kapil Mayawala

Vice President, Clinical Pharmacology, Clinical Development

avatar
Dinesh De Alwis

Senior Vice President, Clinical Drug Development, Generate Biomedicines

avatar
Kevin White

Executive Director, Facilities and Operations

avatar
Heather Van Epps

Executive Director, Head of Therapeutic Research

avatar
Gavin Koh

Executive Director Clinical Development

View Contact details (it's free)
Request Profile Removal